PT2523653T - Processo para a preparação de composições farmacêuticas para a libertação prolongada de análogos de somatostatina - Google Patents
Processo para a preparação de composições farmacêuticas para a libertação prolongada de análogos de somatostatinaInfo
- Publication number
- PT2523653T PT2523653T PT117019380T PT11701938T PT2523653T PT 2523653 T PT2523653 T PT 2523653T PT 117019380 T PT117019380 T PT 117019380T PT 11701938 T PT11701938 T PT 11701938T PT 2523653 T PT2523653 T PT 2523653T
- Authority
- PT
- Portugal
- Prior art keywords
- preparation
- pharmaceutical compositions
- sustained release
- somatostatin analogs
- somatostatin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29464410P | 2010-01-13 | 2010-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2523653T true PT2523653T (pt) | 2018-06-28 |
Family
ID=43743499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT117019380T PT2523653T (pt) | 2010-01-13 | 2011-01-11 | Processo para a preparação de composições farmacêuticas para a libertação prolongada de análogos de somatostatina |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US9352012B2 (pt) |
| EP (2) | EP3378468A1 (pt) |
| JP (1) | JP6029472B2 (pt) |
| KR (1) | KR101915820B1 (pt) |
| CN (2) | CN105456206B (pt) |
| AR (1) | AR079896A1 (pt) |
| AU (1) | AU2011206728B2 (pt) |
| BR (1) | BR112012017435A2 (pt) |
| CA (1) | CA2786181C (pt) |
| DK (1) | DK2523653T3 (pt) |
| EA (1) | EA023128B1 (pt) |
| ES (1) | ES2677012T3 (pt) |
| HK (1) | HK1222807A1 (pt) |
| HU (1) | HUE038200T2 (pt) |
| IL (2) | IL220538A (pt) |
| MX (1) | MX343112B (pt) |
| NZ (1) | NZ600891A (pt) |
| PL (1) | PL2523653T3 (pt) |
| PT (1) | PT2523653T (pt) |
| SG (1) | SG182548A1 (pt) |
| TR (1) | TR201809874T4 (pt) |
| TW (2) | TW201600108A (pt) |
| UA (1) | UA108872C2 (pt) |
| WO (1) | WO2011085957A2 (pt) |
| ZA (1) | ZA201205160B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011085957A2 (en) * | 2010-01-13 | 2011-07-21 | Ipsen Pharma S.A.S. | Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs |
| EP2823808A1 (en) * | 2013-07-09 | 2015-01-14 | Ipsen Pharma S.A.S. | Pharmaceutical composition for a sustained release of lanreotide |
| TW201605488A (zh) | 2013-10-15 | 2016-02-16 | 大塚製藥股份有限公司 | 用以預防及／或治療多囊腎病之藥物 |
| US10086049B2 (en) | 2013-10-22 | 2018-10-02 | Prolynx Llc | Conjugates of somatostatin analogues |
| FR3079421B1 (fr) | 2018-03-28 | 2024-11-15 | Edix Sa | Presentations injectables, seringues et compositions a liberation prolongee et/ou controlee de lanreotide |
| GR1009814B (el) * | 2019-07-29 | 2020-09-11 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα που περιλαμβανει ενα πεπτιδιο αναλογο σωματοστατινης |
| RU2742196C1 (ru) * | 2019-09-11 | 2021-02-03 | Общество с ограниченной ответственностью "Медицинские нанотехнологии" | Фармацевтическая композиция для приготовления инъекционного раствора при использовании в лечении магнитной гипертермии и способ ее получения |
| CN112791177B (zh) * | 2019-10-28 | 2023-06-20 | 深圳翰宇药业股份有限公司 | 注射用生长抑素冻干组合物及其制备方法 |
| LU101974B1 (en) | 2020-08-07 | 2022-02-07 | Pharmathen Sa | Process and apparatus for preparing viscous pharmaceutical formulations |
| WO2022028739A1 (en) | 2020-08-07 | 2022-02-10 | Pharmathen S.A. | Process and apparatus for preparing viscous pharmaceutical formulations |
| GR1010059B (el) * | 2020-08-10 | 2021-08-13 | Φαρματεν Α.Β.Ε.Ε. | Διαδικασια και συσκευη για την παρασκευη παχυρευστων φαρμακοτεχνικων μορφων |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH085913B2 (ja) | 1985-09-12 | 1996-01-24 | ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド | 治療用ソマトスタチン同族体 |
| MD1591B2 (ro) | 1993-08-09 | 2001-01-31 | Biomeasure, Inc. | Derivaţi ai peptidelor cu activitate terapeutică |
| US5595760A (en) | 1994-09-02 | 1997-01-21 | Delab | Sustained release of peptides from pharmaceutical compositions |
| FR2762319A1 (fr) * | 1997-04-18 | 1998-10-23 | Pharma Biotech | Microcapsules presentant une liberation prolongee et leur procede de preparation |
| FR2776520B1 (fr) | 1998-03-25 | 2000-05-05 | Sod Conseils Rech Applic | Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation |
| US6506534B1 (en) * | 1999-09-02 | 2003-01-14 | Fujitsu Limited | Negative resist composition, method for the formation of resist patterns and process for the production of electronic devices |
| IT1318539B1 (it) | 2000-05-26 | 2003-08-27 | Italfarmaco Spa | Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente |
| US7098305B2 (en) | 2001-09-06 | 2006-08-29 | Ardana Bioscience Limited | Sustained release of microcrystalline peptide suspensions |
| RS52966B (en) | 2002-09-27 | 2014-02-28 | Zentaris Gmbh | FORM OF THE THERAPEUTIC APPLICATION OF ACTIVE PEPTIDES WITH THE LONG TERM RELEASE OF THE ACTIVE INGREDIENT |
| US6953447B2 (en) | 2002-10-22 | 2005-10-11 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) | Pre-filled safety injection device with integrated waste collector |
| CN1415378A (zh) * | 2002-10-22 | 2003-05-07 | 南京长澳医药科技有限公司 | 生长抑素冻干粉针及其制备工艺 |
| GB0428151D0 (en) | 2004-12-22 | 2005-01-26 | Novartis Ag | Organic compounds |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| GB0711656D0 (en) | 2007-06-15 | 2007-07-25 | Camurus Ab | Formulations |
| EP2187901B1 (en) * | 2007-09-11 | 2012-08-08 | Mondobiotech Laboratories AG | Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy |
| US20090181068A1 (en) | 2008-01-14 | 2009-07-16 | Dunn Richard L | Low Viscosity Liquid Polymeric Delivery System |
| JP5951991B2 (ja) | 2008-08-12 | 2016-07-13 | ノバルティス アーゲー | 医薬組成物 |
| EP2168983A1 (fr) | 2008-09-30 | 2010-03-31 | Ipsen Pharma | Nouveaux composés octapeptidiques et leur utilisation thérapeutique |
| EP2376060B1 (en) | 2008-12-15 | 2012-09-19 | Novartis AG | Nanoparticle compositions |
| WO2011085957A2 (en) * | 2010-01-13 | 2011-07-21 | Ipsen Pharma S.A.S. | Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs |
-
2011
- 2011-01-11 WO PCT/EP2011/000069 patent/WO2011085957A2/en active Application Filing
- 2011-01-11 EP EP18165921.0A patent/EP3378468A1/en not_active Withdrawn
- 2011-01-11 KR KR1020127021004A patent/KR101915820B1/ko active Active
- 2011-01-11 BR BR112012017435-5A patent/BR112012017435A2/pt not_active Application Discontinuation
- 2011-01-11 HU HUE11701938A patent/HUE038200T2/hu unknown
- 2011-01-11 PT PT117019380T patent/PT2523653T/pt unknown
- 2011-01-11 EA EA201290637A patent/EA023128B1/ru not_active IP Right Cessation
- 2011-01-11 CA CA2786181A patent/CA2786181C/en not_active Expired - Fee Related
- 2011-01-11 NZ NZ600891A patent/NZ600891A/en unknown
- 2011-01-11 US US13/522,297 patent/US9352012B2/en active Active
- 2011-01-11 TW TW104130927A patent/TW201600108A/zh unknown
- 2011-01-11 PL PL11701938T patent/PL2523653T3/pl unknown
- 2011-01-11 DK DK11701938.0T patent/DK2523653T3/en active
- 2011-01-11 ES ES11701938.0T patent/ES2677012T3/es active Active
- 2011-01-11 AU AU2011206728A patent/AU2011206728B2/en active Active
- 2011-01-11 TW TW100100923A patent/TWI536999B/zh active
- 2011-01-11 TR TR2018/09874T patent/TR201809874T4/tr unknown
- 2011-01-11 SG SG2012052403A patent/SG182548A1/en unknown
- 2011-01-11 CN CN201510888218.XA patent/CN105456206B/zh active Active
- 2011-01-11 CN CN201180005703.8A patent/CN102711728B/zh active Active
- 2011-01-11 MX MX2012007802A patent/MX343112B/es active IP Right Grant
- 2011-01-11 JP JP2012548370A patent/JP6029472B2/ja active Active
- 2011-01-11 EP EP11701938.0A patent/EP2523653B1/en active Active
- 2011-01-13 AR ARP110100112A patent/AR079896A1/es not_active Application Discontinuation
- 2011-11-01 UA UAA201209720A patent/UA108872C2/ru unknown
-
2012
- 2012-06-21 IL IL220538A patent/IL220538A/en active IP Right Grant
- 2012-07-11 ZA ZA2012/05160A patent/ZA201205160B/en unknown
-
2016
- 2016-04-27 US US15/139,533 patent/US10206968B2/en active Active
- 2016-09-21 HK HK16111087.3A patent/HK1222807A1/zh unknown
- 2016-10-26 IL IL248510A patent/IL248510A0/en unknown
-
2018
- 2018-12-26 US US16/232,207 patent/US20190167754A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL248510A0 (en) | A process for preparing sustained release pharmaceutical preparations of somatostatin analogs | |
| ZA201208336B (en) | Controlled release pharmaceutical compositions of tapentadol | |
| IL222199A0 (en) | Process for preparation of dopo-derived compounds and compositions thereof | |
| IL231414B (en) | Preparations for the preparation of imaging agents | |
| IL223535A (en) | Solid medicinal compositions | |
| ZA201206254B (en) | Novel salts for the manufacture of pharmaceutical compositions | |
| EP2661273A4 (en) | IRON PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION | |
| HUE031336T2 (hu) | Gyógyszerészeti készítmények | |
| EP2629786A4 (en) | COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS | |
| ZA201103820B (en) | Process for the preparation of tenofovir | |
| EP2554168A4 (en) | PHARMACEUTICAL COMPOSITION WITH CONTROLLED RELEASE | |
| HK1198466A1 (en) | Prasugrel-containing immediate release stable oral pharmaceutical compositions | |
| EP2523654A4 (en) | IMMEDIATE RELEASE COMPOSITIONS OF MEDICAMENTS LABILES ACIDES | |
| AP2012006645A0 (en) | Pharmaceutical compositions comprising paracetamoland process for preparing the same | |
| PL2696846T3 (pl) | Doustne dyspersyjne kompozycje farmaceutyczne | |
| EP2780001A4 (en) | SOLID ORAL ENTECAVIR COMPOSITIONS WITH FAST RELEASE | |
| EP2405754A4 (en) | PHARMACEUTICAL BUPRENORPHINE COMPOSITIONS WITH MODIFIED RELEASE | |
| HK1188959A1 (zh) | 磷霉素藥物組合物 | |
| HK1171020A1 (en) | Process for preparation of pyrimidinylpyrazole compounds | |
| EP2543373A4 (en) | PHARMACEUTICAL COMPOSITION OF LEVOAMLODIPINE COMPOUND | |
| PL2407159T3 (pl) | Kompozycje farmaceutyczne olmesartanu | |
| EP2537851A4 (en) | PROCESS FOR PREPARING B-GLYCOSIDE COMPOUNDS | |
| EP2560678A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| ZA201205978B (en) | Solid pharmaceutical composition for buccal administration of agomelatine | |
| GB201407689D0 (en) | Pharmaceutical compositions of antihypertensives |